[Construction and in vitro evaluation of an infectious clone of the equine infectious anemia virus vaccine strain EIAV(FDDV) with four reverse-mutated vaccine-specific sites in the S2 gene].

This research explores the function of the S2 gene in the equine infectious anemia virus (EIAV), focusing on its role in weakening the impact of the disease in Chinese EIAV vaccine strains. By introducing reverse-mutations into the vaccine, scientists noted minor changes to the virus’s replication speed, suggesting the S2 gene doesn’t significantly affect viral replication in vitro.

Understanding the Function of the S2 Gene in EIAV

• The researchers sought to comprehend the role of the S2 gene in the EIAV and how it contributes to the attenuation, or weakening, of the Chinese EIAV vaccine strains.
• To achieve this, the S2 gene in the EIAV vaccine strain (EIAV FDDV) was reverse-mutated and the results were evaluated in vitro, or outside the body in a controlled laboratory setting.

The Reverse Mutation Process

• Reverse-mutated means returning to the original sequence of the gene. This was performed on all four vaccine-specific sites on the S2 gene with an EIAV FDDV infectious clone, referenced as pFDDV3-8.
• The sequences were reverse-mutated to match the virulent (disease-causing) strain EIAV (DV115) to observe any changes in function.
• A molecular clone, pFDDVS2r1-3-4-5, was then used to infect fetal donkey dermal (FDD) cells, to resurrect the resultant virus, vpFDDVS2r1-3-4-5.

Evaluating the Virus

• The researchers used techniques such as RT-PCR, immune fluorescence assay, and reverse transcriptase activity assay to confirm the production and replication of vpFDDVS2r1-3-4-5 in FDD cells.
• They also used electron microscopy to observe the EIAV virions, or viral particles.

Results and Implications

• A comparison of the replication speeds of the reverse-mutated virus vpFDDVS2r1-3-4-5 and the original vaccine strain vpFDDV3-8 showed that the former replicated only slightly slower than the original strain.
• This suggests that the mutations in the S2 gene didn’t significantly alter the virus’s replication in vitro.

Further Research

• The research indicates a need for further in vivo studies (inside the body) to better understand the relationship between the S2 gene and the attenutation process of EIAV vaccines.